- For the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC)
Coverage of drugs is first determined by the memberís pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.
|Drug||Dosing Regimen||Dose Limit/ Maximum Dose|
300 mg PO QD
300 mg QD
|Drug||Dosing Regimen||Authorization Limit|
140 mg PO QD
Treatment continues until no longer clinically beneficial or
until unacceptable toxicity occurs.
Length of Benefit